Skip to main content
. 2022 Dec 12;76(8):1358–1363. doi: 10.1093/cid/ciac941

Figure 3.

Figure 3.

Vaccine effectiveness against outpatient influenza A(H3N2)-associated illness by time since vaccination, 4 October 2021–30 April 2022, United States. Adjusted for study site, age, month of illness onset, race/ethnicity, and self-rated general health status and included all participants aged ≥6 mo. Abbreviations: CI, confidence interval; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; VE, vaccine effectiveness.